Scientific Advisory Board

The Brigham Research Institute’s Scientific Advisory Board is tasked with providing strategic counsel and vision to further enhance research at Brigham and Women’s Hospital. Chaired by former President and CEO of the Novartis Institutes for BioMedical Research, James (Jay) Bradner, MD, the board is comprised of scientists, venture capitalists and pharmaceutical leaders.